AMITRIPTYLINE THERAPY OF OBSESSIVE-COMPULSIVE NEUROSIS

[1] *AM PSYCH ASS TASK, DIAGN STAT MAN III P

[2] ANANTH J, 1979, AM J PSYCHIAT, V136, P700

[3] ANANTH J, 1976, PSYCHOSOMATICS, V17, P180

[4] ANDEN NE, 1968, BRIT J PHARMACOL, V34, P1

[5] BAUER G, 1969, ARZNEI-FORSCHUNG, V19, P1642

[6] CALSSON A, 1969, EUR J PHARM, V5, P357

[7] CAPSTICK N, 1971, PSYCHOSOMATICS, V12, P332

[8] HAMMER WOLFGANG, 1967, LIFE SCI, V6, P1895, DOI 10.1016/0024-3205(67)90218-4

[9] HINSIE LE, 1974, PSYCHIATRIC DICTIONA

[10] HUSSAIN MZ, 1970, CAN MED ASSOC J, V103, P648

[1] *AM PSYCH ASS TASK, DIAGN STAT MAN III P

[2] ANANTH J, 1979, AM J PSYCHIAT, V136, P700

[3] ANANTH J, 1976, PSYCHOSOMATICS, V17, P180

[4] ANDEN NE, 1968, BRIT J PHARMACOL, V34, P1

[5] BAUER G, 1969, ARZNEI-FORSCHUNG, V19, P1642

[6] CALSSON A, 1969, EUR J PHARM, V5, P357

[7] CAPSTICK N, 1971, PSYCHOSOMATICS, V12, P332

[8] HAMMER WOLFGANG, 1967, LIFE SCI, V6, P1895, DOI 10.1016/0024-3205(67)90218-4

[9] HINSIE LE, 1974, PSYCHIATRIC DICTIONA

[10] HUSSAIN MZ, 1970, CAN MED ASSOC J, V103, P648